*Shotaro Kawano1, Toshihiko Kuriu2, Sayaka Katayama1, Manaka Otomo1, Daiki Miura1, Hotaka Fukushima1, Kazuhiro Takuma3, Fumihito Ono4, Hitoshi Hashimoto5,6,7,8,9,10, Ryota Hashimoto6, Takanobu Nakazawa1,6
(1. Department of Bioscience, Graduate School of Life Sciences, Tokyo University of Agriculture, Tokyo, Japan, 2. Osaka Medical and Pharmaceutical University, Research and Development Center, Osaka, Japan, 3. Department of Pharmacology, Graduate School of Dentistry, Osaka University, Osaka, Japan, 4. Department of Physiology, Division of Life Science, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan, 5. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 6. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 7. United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Japan, 8. Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan, 9. Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan, 10. Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University, Osaka, Japan)
キーワード:Psychiatric disorder, 3q29 deletion, iPS cells, neural differentiation
抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードを入力して認証してください。